LR

Lilu Ram Bansal

Active Director Director DIN 10870915
DIN 10870915 First appointment Dec 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Lilu Ram Bansal

Data last updated:

Lilu Ram Bansal is a Director at Osher Pharmaceuticals (India) Private Limited (since 2024). The company operates in Paper.

DIN 10870915
Primary Designation Director
Industry Paper
First Appointment 13 Dec 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Dec 20242024Active

Directorship timeline

Open interactive timeline →
Osher Pharmaceuticals (India) Private Limited
Premium access

Shareholding and investment profile for Lilu Ram Bansal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lilu Ram Bansal

Lilu Ram Bansal currently holds 1 directorship: Osher Pharmaceuticals (India) Private Limited (Director, since 13 Dec 2024).

Lilu Ram Bansal was first appointed on 13 Dec 2024 as Director at Osher Pharmaceuticals (India) Private Limited.

The current boards of Lilu Ram Bansal's companies include Bhavik Hemant Shethia (Osher Pharmaceuticals (India) Private Limited), Pankaj Dua (Osher Pharmaceuticals (India) Private Limited), Pankaj Gupta (Osher Pharmaceuticals (India) Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available